Literature DB >> 8836117

The role of changes in the sensitivity of hepatic mitochondrial overt carnitine palmitoyltransferase in determining the onset of the ketosis of starvation in the rat.

L Drynan1, P A Quant, V A Zammit.   

Abstract

The relationships between the increase in blood ketone-body concentrations and several parameters that can potentially influence the rate of hepatic fatty acid oxidation were studied during progressive starvation (up to 24 h) in the rat in order to discover whether the sensitivity of mitochondrial overt carnitine palmitoyltransferase (CPT I) to malonyl-CoA plays an important part in determining the intrahepatic potential for fatty acid oxidation during the onset of ketogenic conditions. A rapid increase in blood ketone-body concentration occurred between 12 and 16 h of starvation, several hours after the marked fall in hepatic malonyl-CoA and in serum insulin concentrations and doubling of plasma non-esterfied fatty acid (NEFA) concentration. Consequently, both the changes in hepatic malonyl-CoA and serum NEFA preceded the increase in blood ketone-body concentration by several hours. The maximal activity of CPT I increased gradually throughout the 24 h period of starvation, but the increases did not become significant before 18 h of starvation. By contrast, the sensitivity of CPT I to malonyl-CoA and the increase in blood ketone-body concentration followed an identical time course, demonstrating the central importance of this parameter in determining the ketogenic response of the liver to the onset of the starved state.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836117      PMCID: PMC1217684          DOI: 10.1042/bj3180767

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  Sensitivity of inhibition of rat liver mitochondrial outer-membrane carnitine palmitoyltransferase by malonyl-CoA to chemical- and temperature-induced changes in membrane fluidity.

Authors:  M P Kolodziej; V A Zammit
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

2.  The short-term regulation of hepatic acetyl-CoA carboxylase during starvation and re-feeding in the rat.

Authors:  M R Munday; M R Milic; S Takhar; M J Holness; M C Sugden
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

3.  Mature carnitine palmitoyltransferase I retains the N-terminus of the nascent protein in rat liver.

Authors:  M P Kolodziej; V A Zammit
Journal:  FEBS Lett       Date:  1993-08-02       Impact factor: 4.124

4.  Determination of malonyl-coenzyme A in rat heart, kidney, and liver: a comparison between acetyl-coenzyme A and butyryl-coenzyme A as fatty acid synthase primers in the assay procedure.

Authors:  B Singh; J A Stakkestad; J Bremer; B Borrebaek
Journal:  Anal Biochem       Date:  1984-04       Impact factor: 3.365

5.  Sensitivity of carnitine acyltransferase I to malonly-CoA inhibition in isolated rat liver mitochondria is quantitatively related to hepatic malonyl-CoA concentration in vivo.

Authors:  I N Robinson; V A Zammit
Journal:  Biochem J       Date:  1982-07-15       Impact factor: 3.857

6.  Development and characterization of a polyclonal antibody against rat liver mitochondrial overt carnitine palmitoyltransferase (CPT I). Distinction of CPT I from CPT II and of isoforms of CPT I in different tissues.

Authors:  M P Kolodziej; P J Crilly; C G Corstorphine; V A Zammit
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

7.  Cholate extracts of mitochondrial outer membranes increase inhibition by malonyl-CoA of carnitine palmitoyltransferase-I by a mechanism involving phospholipids.

Authors:  R L Mynatt; J J Greenhaw; G A Cook
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

Review 8.  Monitoring the partitioning of hepatic fatty acids in vivo: keeping track of control.

Authors:  V A Zammit; A M Moir
Journal:  Trends Biochem Sci       Date:  1994-08       Impact factor: 13.807

9.  Insulin-independent and extremely rapid switch in the partitioning of hepatic fatty acids from oxidation to esterification in starved-refed diabetic rats. Possible roles for changes in cell pH and volume.

Authors:  A M Moir; V A Zammit
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

10.  Monitoring of changes in hepatic fatty acid and glycerolipid metabolism during the starved-to-fed transition in vivo. Studies on awake, unrestrained rats.

Authors:  A M Moir; V A Zammit
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

View more
  6 in total

1.  Lipid molecular order in liver mitochondrial outer membranes, and sensitivity of carnitine palmitoyltransferase I to malonyl-CoA.

Authors:  V A Zammit; C G Corstorphine; M P Kolodziej; F Fraser
Journal:  Lipids       Date:  1998-04       Impact factor: 1.880

2.  Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone.

Authors:  Mark J Holness; Karen Bulmer; Nicholas D Smith; Mary C Sugden
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

3.  Mitochondrial and metabolic effects of nucleoside reverse transcriptase inhibitors (NRTIs) in mice receiving one of five single- and three dual-NRTI treatments.

Authors:  Reine Note; Caroline Maisonneuve; Philippe Lettéron; Gilles Peytavin; Fatima Djouadi; Anissa Igoudjil; Marie-Christine Guimont; Michel Biour; Dominique Pessayre; Bernard Fromenty
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

4.  The SGLT2 inhibitor dapagliflozin promotes systemic FFA mobilization, enhances hepatic β-oxidation, and induces ketosis.

Authors:  Kristina Wallenius; Tobias Kroon; Therese Hagstedt; Lars Löfgren; Maria Sörhede-Winzell; Jeremie Boucher; Daniel Lindén; Nicholas D Oakes
Journal:  J Lipid Res       Date:  2022-02-02       Impact factor: 5.922

5.  Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice.

Authors:  Alicia G Gómez-Valadés; Andrés Méndez-Lucas; Anna Vidal-Alabró; Francese X Blasco; Miguel Chillon; Ramon Bartrons; Jordi Bermúdez; José C Perales
Journal:  Diabetes       Date:  2008-04-28       Impact factor: 9.461

6.  A case of montelukast-induced churg-strauss syndrome associated with liver dysfunction.

Authors:  Keiji Matsui; Kosuke Nishijima
Journal:  Case Reports Hepatol       Date:  2011-07-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.